• Assess whether decentralized trial models improve recruitment among geographically diverse and underrepresented populations.
• Evaluate participant satisfaction, convenience, and retention in remote and hybrid clinical trial settings.
• Investigate the quality, reliability, and regulatory acceptability of remotely collected clinical data.
• Identify operational, technological, and ethical challenges associated with decentralized trial implementation.

• Integrating patient insights into every stage of the medicine lifecycle, from discovery to post-market support
• Designing clinical trials that reduce patient burden and improve recruitment, diversity, and retention
• Using patient-reported outcomes and real-world evidence to demonstrate value and improve therapies
• Building transparent partnerships between pharmaceutical companies, clinicians, and patient organisations

• This session looks at what it really means to do patient engagement differently in ways that reach communities who are too often left out of health research.
• We will share practical, creative and culturally grounded approaches to gathering genuine insights, sharing outreach, and building trust with underrepresented communities and why these matters for making clinical trials and health research more inclusive and effective.

• Explore models for integrating patient experiences and preferences into continuous healthcare improvement processes.
• Assess the role of patients in co-creating quality improvement initiatives and healthcare innovations.
• Evaluate how patient participation contributes to organizational learning and system performance.
• Develop frameworks for embedding patient partnership into governance, data systems, and clinical practice.

Richard Cassidy, SVP – Rx+ Business Accelerator, Astellas Pharma